French National Registry of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator
Launched by PARIS SUDDEN DEATH EXPERTISE CENTER · Feb 9, 2019
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is part of a French national registry that aims to gather information about patients who have a heart condition called tetralogy of Fallot and who use an implantable cardioverter defibrillator (ICD). The ICD is a device that helps prevent sudden cardiac death by correcting dangerous heart rhythms. Researchers want to learn more about how these patients are doing and what their experiences are with the ICD.
To be eligible for this study, participants must have been diagnosed with tetralogy of Fallot and currently have an ICD. The trial is open to all adults aged 18 and older, regardless of gender. If you join the study, you can expect to contribute valuable information that may help improve care for others with similar conditions. Your participation could help researchers understand more about living with tetralogy of Fallot and the role of ICDs in managing heart health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • tetralogy of Fallot
- • implantable cardioverter defibrillator
- Exclusion Criteria:
- • age \< 18 years
About Paris Sudden Death Expertise Center
The Paris Sudden Death Expertise Center is a leading clinical research organization dedicated to advancing the understanding and prevention of sudden cardiac death. Situated at the forefront of cardiovascular research, the center focuses on innovative clinical trials and expert analyses to identify risk factors, improve diagnostic methods, and develop effective interventions. With a multidisciplinary team of renowned cardiologists, researchers, and healthcare professionals, the center aims to enhance patient outcomes through rigorous scientific inquiry and collaboration with academic institutions and healthcare providers. Its commitment to excellence in research and patient care positions the Paris Sudden Death Expertise Center as a pivotal contributor to the global fight against sudden cardiac events.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Victor Waldmann, MD
Principal Investigator
Paris Sudden Death Expertise Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials